• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设计一个“理想”的物质使用障碍治疗中心:使用阿片类药物治疗药物使用障碍的人的观点。

Designing an "Ideal" Substance Use Disorder Treatment Center: Perspectives of People Who Have Utilized Medications for Opioid Use Disorder.

机构信息

University of Central Florida, Orlando, Department of Health Informatics, Florida, USA.

University of Central Florida, Orlando, Department of Internal Medicine Florida, USA.

出版信息

Qual Health Res. 2021 Feb;31(3):512-522. doi: 10.1177/1049732320971231. Epub 2020 Nov 19.

DOI:10.1177/1049732320971231
PMID:33213261
Abstract

Treatment preferences of people with opioid use disorder (OUD) have been underexplored, especially among those with a history of utilizing medications for opioid use disorder (MOUD). Therefore, we sought to understand preferred characteristics of substance use disorder treatment centers among people recovering from OUD with a history of MOUD utilization. We recruited 30 individuals from eight states through snowball sampling initiated at three syringe exchange programs. Telephone interviews were audio-recorded and transcribed in 2018-2019. Inductive thematic analysis in Dedoose software occurred iteratively with recruitment. The following were "ideal" treatment center themes: a menu of treatment options, including MOUD and nonspiritual peer support groups; an integrated system with multiple care levels (e.g., outpatient, residential); a harm reduction approach, including for goal setting and success measures; adjunctive support services (e.g., housing); and employees with recovery experience and professional education. Many preferences directly related to core principles of person-centered care and harm reduction.

摘要

治疗偏好的人阿片类药物使用障碍(OUD)一直被低估,尤其是那些有利用药物治疗阿片类药物使用障碍(MOUD)的历史。因此,我们试图了解那些有 MOUD 利用史的阿片类药物使用障碍康复者对物质使用障碍治疗中心的偏好特征。我们通过在三个注射器交换项目中启动的滚雪球抽样方法,从八个州招募了 30 人。电话访谈在 2018-2019 年进行了音频记录和转录。在德多斯软件中,归纳主题分析是迭代进行的,同时也进行了招募。以下是“理想”治疗中心的主题:治疗选择的菜单,包括 MOUD 和非精神同伴支持小组;一个具有多个护理水平的综合系统(如门诊、住院);一种减少伤害的方法,包括目标设定和成功措施;辅助支持服务(如住房);以及具有康复经验和专业教育的员工。许多偏好直接与以人为本的护理和减少伤害的核心原则相关。

相似文献

1
Designing an "Ideal" Substance Use Disorder Treatment Center: Perspectives of People Who Have Utilized Medications for Opioid Use Disorder.设计一个“理想”的物质使用障碍治疗中心:使用阿片类药物治疗药物使用障碍的人的观点。
Qual Health Res. 2021 Feb;31(3):512-522. doi: 10.1177/1049732320971231. Epub 2020 Nov 19.
2
Stigmatization of medications for opioid use disorder in 12-step support groups and participant responses.12步支持小组中针对阿片类药物使用障碍药物的污名化及参与者的反应。
Subst Abus. 2022;43(1):415-424. doi: 10.1080/08897077.2021.1944957. Epub 2021 Jul 2.
3
Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder.比较一组患有阿片类药物使用障碍的白人个体开始和停止美沙酮、丁丙诺啡和纳曲酮治疗的原因。
J Addict Med. 2020 Jul/Aug;14(4):e44-e52. doi: 10.1097/ADM.0000000000000584.
4
Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study.患有阿片类药物使用障碍的人在 COVID-19 大流行期间的经历:一项定性研究。
PLoS One. 2021 Jul 29;16(7):e0255396. doi: 10.1371/journal.pone.0255396. eCollection 2021.
5
Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study.物质使用障碍患者住院管理戒断(脱毒)后寻求治疗的障碍:一项定性研究。
J Subst Abuse Treat. 2022 Nov;142:108870. doi: 10.1016/j.jsat.2022.108870. Epub 2022 Sep 1.
6
Peer-delivered harm reduction and recovery support services: initial evaluation from a hybrid recovery community drop-in center and syringe exchange program.同伴提供的减少伤害和康复支持服务:从混合康复社区便民服务中心和注射器交换项目的初步评估。
Harm Reduct J. 2018 Oct 22;15(1):52. doi: 10.1186/s12954-018-0258-2.
7
The effect of medications for opioid use disorder (MOUD) on residential treatment completion and retention in the US.美沙酮维持治疗药物对美国住院治疗完成和保留的影响。
Drug Alcohol Depend. 2020 Jul 1;212:108067. doi: 10.1016/j.drugalcdep.2020.108067. Epub 2020 May 15.
8
College students' perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities.两所美国大学的大学生对阿片类药物使用障碍治疗方法的认知和感知有用性。
Am J Drug Alcohol Abuse. 2020 Sep 2;46(5):589-603. doi: 10.1080/00952990.2020.1757686. Epub 2020 Jun 16.
9
Expanding Contraception Access for Women With Opioid-Use Disorder: A Qualitative Study of Opportunities and Challenges.扩大阿片类药物使用障碍女性的避孕途径:机遇与挑战的定性研究
Am J Health Promot. 2020 Nov;34(8):909-918. doi: 10.1177/0890117120927327. Epub 2020 May 29.
10
Perspectives on the HIV continuum of care among adult opioid users in New York City: a qualitative study.纽约市成年阿片类药物使用者中 HIV 连续护理的观点:一项定性研究。
Harm Reduct J. 2019 Oct 12;16(1):58. doi: 10.1186/s12954-019-0329-z.

引用本文的文献

1
Spatial accessibility of substance use disorder treatment programs, compared with other health care facilities, in New York State, 2024.2024年纽约州物质使用障碍治疗项目与其他医疗保健机构相比的空间可达性。
Addict Sci Clin Pract. 2025 Jul 31;20(1):60. doi: 10.1186/s13722-025-00592-9.
2
"I feel like people would look at me like I'm dirty or like I'm a thief:" a qualitative exploration of interpersonal and intrapersonal experiences that influence recovery among adults at risk of opioid-related overdose.“我感觉人们会像看一个脏兮兮的人或者小偷一样看我”:对影响有阿片类药物过量使用风险的成年人康复的人际和内心体验的质性探索。
Front Public Health. 2025 Feb 28;13:1464075. doi: 10.3389/fpubh.2025.1464075. eCollection 2025.
3
Social Network Barriers to Extended-Release Naltrexone Within Rural Appalachia: Perspectives from Justice-Involved Clients and Clinicians.
美国阿巴拉契亚农村地区长效纳曲酮的社交网络障碍:涉司法客户和临床医生的观点
Subst Use Misuse. 2025;60(5):758-765. doi: 10.1080/10826084.2024.2447430. Epub 2025 Jan 14.
4
Patient experiences in outpatient substance use disorder treatment: A qualitative study exploring both clinical and non-clinical contexts.门诊物质使用障碍治疗中的患者体验:一项探索临床和非临床背景的定性研究。
J Subst Use Addict Treat. 2025 Feb;169:209581. doi: 10.1016/j.josat.2024.209581. Epub 2024 Nov 16.
5
Exploring the Lived Experiences of Medication for Opioid use Disorder Treatment: A Qualitative Study among a Crowdsourced Convenience Sample.探索阿片类物质使用障碍治疗药物的生活体验:一项众包便利样本的定性研究
Community Ment Health J. 2025 Apr;61(3):411-419. doi: 10.1007/s10597-024-01345-9. Epub 2024 Sep 5.
6
Implementation of an office-based addiction treatment model for Medicaid enrollees: A mixed methods study.基于办公室的医疗补助参保者成瘾治疗模式的实施:一项混合方法研究。
J Subst Use Addict Treat. 2024 Jan;156:209212. doi: 10.1016/j.josat.2023.209212. Epub 2023 Nov 5.
7
Supervised on-site dosing in injectable opioid agonist treatment-considering the patient perspective. Findings from a cross-sectional interview study in two German cities.在注射用阿片类激动剂治疗中进行监督现场给药——从患者角度出发。在德国两个城市进行的横断面访谈研究的结果。
Harm Reduct J. 2023 Nov 1;20(1):162. doi: 10.1186/s12954-023-00896-6.
8
Opioid use disorder treatment and the role of New Jersey Medicaid policy changes: perspectives of office-based buprenorphine providers.阿片类药物使用障碍治疗与新泽西州医疗补助政策变化的作用:基层美沙酮维持治疗提供者的观点。
Am J Drug Alcohol Abuse. 2023 Sep 3;49(5):606-617. doi: 10.1080/00952990.2023.2234075. Epub 2023 Jul 28.
9
Opioid use and HIV treatment services experiences among male criminal justice-involved persons in South Africa: a qualitative study.南非男性刑事司法涉案人员中阿片类药物使用和艾滋病毒治疗服务体验:一项定性研究。
Harm Reduct J. 2023 Jul 21;20(1):90. doi: 10.1186/s12954-023-00834-6.
10
Three decades of research in substance use disorder treatment for syringe services program participants: a scoping review of the literature.30 年来针对注射毒品者的美沙酮维持治疗方案参与者的物质使用障碍治疗研究:文献综述。
Addict Sci Clin Pract. 2023 Jun 10;18(1):40. doi: 10.1186/s13722-023-00394-x.